17.43MMarket Cap
LossP/E TTM
Institutional Confidence
Currency: USD Updated: 2026-06-30The current institutional shareholding score of Atossa Therapeutics Inc is 3.00, ranking 192 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 22.09%, representing a quarter-over-quarter decrease of 14.88%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 1.27% of shares outstanding, with 16.22% increase in holdings.
Institutional Shareholding
Shareholder Activity
Heights Capital Management, Inc.
Columbia Threadneedle Investments (US)
BlackRock Institutional Trust Company, N.A.
UBS Financial Services, Inc.
Geode Capital Management, L.L.C.
Millennium Management LLC
Jacobs Levy Equity Management, Inc.